As of August 28, 2026, Bristol-Myers Squibb Co (BMYMP) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Bristol-Myers Squibb Co has 2.04B shares outstanding, 2537 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
💰Cash Runway—
📊Float Risk—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for BMYMP.
Market Data
Market CapN/A
Shares Outstanding2.04B
FloatN/A
Cash$8.89B
Debt$43.12B
Short InterestN/A
Institutional Holdings
QoQ: ↑ 20.0% shares (2026Q1 vs prior)
2537 institutional holders · 2.10B shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
264.64M shares
#2
BlackRock, Inc.
171.68M shares
#3
STATE STREET CORP
98.56M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track BMYMP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BMYMP — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.
- Float Risk is excluded because public-float data is unavailable.